The UL was established for generally healthy people, and the FNB noted that individuals with liver or kidney disease, Parkinson's disease, depression, or inherited trimethylaminuria might be at increased risk of adverse effects when consuming choline at levels near the UL (32)
Furthermore, studies show that L-carnitine is reduced in patients with liver disease, diabetes and cardiovascular disease [6,7,8] and supplementation with L-carnitine has been reported to improve liver inflammation and reduce liver enzymes and liver fat in these patients [9,10,11,12]
There was a significantly higher level (p = 0.000) of glutathione peroxidase in the case (55.39 2.87) compared to the control (42.59 2.41)
Not for human or animal consumption, injection, diagnosis, or therapeutic application